scholarly journals Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?

RMD Open ◽  
2016 ◽  
Vol 2 (1) ◽  
pp. e000283 ◽  
Author(s):  
Roxana Rubio Vargas ◽  
Rosaline van den Berg ◽  
Miranda van Lunteren ◽  
Zineb Ez-Zaitouni ◽  
Pauline A C Bakker ◽  
...  
2020 ◽  
Vol 3 (2) ◽  
pp. 71-85
Author(s):  
Raouf Merza ◽  
Kurdistan Ali ◽  
Dlair Mohamad ◽  
Sundus Wahhab

Find out the relationship between body mass index (BMI) and W.C with disease activity scorein AS patients and its association with clinical characteristics of AS. One hundred and five patients (75 male and 30 female) who visited rheumatology and medical rehabilitation centerin Sulaimani city were recorded in this cross-sectional study. Disease activity was measured by ASDAS-ESR in the hand-held calculator.BMI was calculated and waist circumference(W.C.) was measured and both were evaluated with disease activity score and disease characteristics in those with normal BMI and W.C and those with abnormal BMI and W.C.Data of one hundred and five patients were involved in this study with a mean age of 37±9.5 years with the predominance of male gender (71.4%). The mean BMI of the patients was27.2±4.6 kg/m², 28.6% of them were obese and 35.2% of them were overweight. Patients who were overweight, obese and increased W.C had significantly higher disease activity scoresand older compared to those who had normal BMI and W.C(p value<0.05).There was no statistically significant difference between the two groups in terms of peripheral arthritis,disease duration, clinical characteristics of AS, and gender (P value>0.05). Overweight, obesity and increased W.C are common among AS patients and significantly related to disease activity score and age, but not with disease characteristics and gender


RMD Open ◽  
2020 ◽  
Vol 6 (1) ◽  
pp. e001225
Author(s):  
Jean W Liew ◽  
Irvin J Huang ◽  
Diana N Louden ◽  
Namrata Singh ◽  
Lianne S Gensler

ObjectivesIn axial spondyloarthritis (axSpA), higher body mass index (BMI) is associated with worse outcomes including response to biologics. Further clarity is needed on whether BMI is associated with disease activity overall, independent of treatment response. We performed a systematic review and meta-analysis to assess the association between BMI and disease activity as reported by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) or Ankylosing Spondylitis Disease Activity Score (ASDAS) in axSpA.MethodsWe systematically searched for studies evaluating BMI and disease activity as the exposure and outcome of interest, respectively, in axSpA. Using random effects models, we estimated summary standardised mean differences (SMDs) and 95% CIs of BASDAI or ASDAS, comparing obese (BMI>30 kg/m2) or overweight/obese (BMI>25 kg/m2) individuals to those with normal BMI (18.5–24.9 kg/m2).ResultsTwelve studies were included in the meta-analysis. Among all studies reporting the BASDAI at baseline, the pooled SMD of the BASDAI for those with an obese or overweight/obese BMI compared to a normal BMI was 0.38 (95% CI 0.21 to 0.55, I2 =75.2%), indicating a significant association of higher BMI with higher BASDAI score. The pooled SMD of the ASDAS for those with an obese or overweight/obese BMI compared to a normal BMI was 0.40 (95% CI 0.27 to 0.54, I2=0%). Findings were robust across subgroup analyses.ConclusionThese results demonstrate an association between an overweight/obese BMI and higher disease activity in studies of axSpA. Future longitudinal studies of BMI and disease activity should assess how this association changes over time.


Sign in / Sign up

Export Citation Format

Share Document